Circassia Group PLC
LSE:CIR
Circassia Group PLC
Revenue
Circassia Group PLC
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Circassia Group PLC
LSE:CIR
|
Revenue
£31.3m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Revenue
$6.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Revenue
$1.7m
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Revenue
$41.6m
|
CAGR 3-Years
55%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Revenue
£249.4m
|
CAGR 3-Years
102%
|
CAGR 5-Years
60%
|
CAGR 10-Years
N/A
|
|
Genus PLC
LSE:GNS
|
Revenue
£673.1m
|
CAGR 3-Years
6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
6%
|
See Also
What is Circassia Group PLC's Revenue?
Revenue
31.3m
GBP
Based on the financial report for Dec 31, 2022, Circassia Group PLC's Revenue amounts to 31.3m GBP.
What is Circassia Group PLC's Revenue growth rate?
Revenue CAGR 5Y
-8%
Over the last year, the Revenue growth was 12%. The average annual Revenue growth rates for Circassia Group PLC have been -3% over the past three years , -8% over the past five years .